September 21, 2012

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

November 21, 2011

A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.

October 11, 2011

The Food and Drug Administration has approved Mylan’s promethazine hydrochloride tablets, a generic drug for treating allergies, in the 12.5-mg, 25-mg and 50-mg strengths.

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

August 23, 2011

The Food and Drug Administration will decide whether or not to approve a new usage for a cancer drug made by Amgen by next year, the drug maker said.

December 13, 2010

A drug made by Amgen was able to delay certain bone problems in patients with advanced breast cancer better than a competing drug, according to study results presented at the 33rd annual San Antonio Breast Cancer Symposium.

November 18, 2010

The Food and Drug Administration has approved a treatment for preventing skeletal injuries in patients...

November 4, 2010

Biotech company Amgen took home a top award for one of its drugs at an...

July 18, 2010

The Food and Drug Administration has given priority review to an application from Amgen for...

June 1, 2010

The Food and Drug Administration has approved a new drug from Amgen for osteoporosis, Amgen...

May 18, 2010

Amgen has submitted a regulatory approval application to the Food and Drug Administration for a...

February 8, 2010

An investigational drug made by Amgen for treating prostate cancer that had spread to the...